Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaled Ramadan

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMC Plant Biology|December 27, 2025
The effect of ethyl methanesulfonate (EMS) and environmental factors on soybean traitsKhaled Ramadan, Souhail Nader, Loubna Mokrani, et al.
Journal of Pharmaceutical Analysis|March 11, 2024
Mapping the metabolic responses to oxaliplatin-based chemotherapy with <i>in vivo</i> spatiotemporal metabolomicsMariola Olkowicz, Khaled Ramadan, Hernando Rosales-Solano, et al.
Transplantation Reviews (Orlando, Fla.)|July 5, 2021
Surfactant therapy in lung transplantation: A systematic review and meta-analysisAadil Ali, Tommaso Pettenuzzo, Khaled Ramadan, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 2, 2020
A model to assess acute and delayed lung toxicity of oxaliplatin during in vivo lung perfusionKhaled Ramadan, Bruno Gomes, Mauricio Pipkin, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?Warren Fingrut, Wendy Davis, Eric McGinnis, et al.
Genes, Chromosomes & Cancer|September 23, 2015
Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, CanadaSteven J T Huang, Tanya L Gillan, Alina S Gerrie, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2017
Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, CanadaJennifer Goy, Tanya L Gillan, Helene Bruyere, et al.
Leukemia & Lymphoma|April 22, 2023
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, CanadaRania S Khelifi, Steven J Huang, Kerry J Savage, et al.
Journal of Pharmaceutical Analysis|March 15, 2021
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusionBarbara Bojko, Nikita Looby, Mariola Olkowicz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 27, 2020
An extracellular oxygen carrier during prolonged pulmonary preservation improves post-transplant lung functionAadil Ali, Yui Watanabe, Marcos Galasso, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMC Plant Biology|December 27, 2025
The effect of ethyl methanesulfonate (EMS) and environmental factors on soybean traitsKhaled Ramadan, Souhail Nader, Loubna Mokrani, et al.
Journal of Pharmaceutical Analysis|March 11, 2024
Mapping the metabolic responses to oxaliplatin-based chemotherapy with <i>in vivo</i> spatiotemporal metabolomicsMariola Olkowicz, Khaled Ramadan, Hernando Rosales-Solano, et al.
Transplantation Reviews (Orlando, Fla.)|July 5, 2021
Surfactant therapy in lung transplantation: A systematic review and meta-analysisAadil Ali, Tommaso Pettenuzzo, Khaled Ramadan, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 2, 2020
A model to assess acute and delayed lung toxicity of oxaliplatin during in vivo lung perfusionKhaled Ramadan, Bruno Gomes, Mauricio Pipkin, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Reevaluating Patient Eligibility for Inotuzumab Ozogamicin Based on CD22 Expression: Is Dim Expression Sufficient?Warren Fingrut, Wendy Davis, Eric McGinnis, et al.
Genes, Chromosomes & Cancer|September 23, 2015
Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, CanadaSteven J T Huang, Tanya L Gillan, Alina S Gerrie, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2017
Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, CanadaJennifer Goy, Tanya L Gillan, Helene Bruyere, et al.
Leukemia & Lymphoma|April 22, 2023
Population-level impact of ibrutinib for chronic lymphocytic leukemia in British Columbia, CanadaRania S Khelifi, Steven J Huang, Kerry J Savage, et al.
Journal of Pharmaceutical Analysis|March 15, 2021
Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusionBarbara Bojko, Nikita Looby, Mariola Olkowicz, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 27, 2020
An extracellular oxygen carrier during prolonged pulmonary preservation improves post-transplant lung functionAadil Ali, Yui Watanabe, Marcos Galasso, et al.
Pageof 3